Interventional Oncology Market

Interventional oncology market is likely to exhibit a promising growth curve as far as the short-term outlook is considered. The report will uncover the insights into how the market growth will unfold in the next few years.

Mounting Preference for Minimally Invasive Procedures to Fuel Growth of Interventional Oncology Market

Interventional oncology: a catheter-based approach that delivers treatment directly to the tumour, is an effective minimally invasive treatment for certain types of cancer. Therapies, including surgery, radiation and chemotherapy have many side effects. That’s less so with interventional oncology, minimising the side effects, and maximising the quality of life as well as patient comfort. Increasing perception as a highly precise treatment for symptomatic relief, tumour control, effective remission, and even in some cases complete cure, interventional oncology is expected to gain greater prominence. As it is emerging as a popular treatment option for patients with liver, colorectal, lung, bone/soft tissue, kidney, and metastatic cancers, interventional oncology market is expected to thrive at a notable pace. These image-guided procedures can be performed in place of or in combination with other cancer treatments to provide a truly comprehensive care.

Interventional oncology has made significant inroads since 2000 beginning to the point that many treatments are now considered “standard of care” and included into all the treatment guidelines. The procedure precisely targets tumours while sparing healthy tissue, is used in an outpatient setting – no need for hospitalisation, faster recovery – can resume normal activity in 24-48 hours. With these procedures’ benefits over conventional treatment methods, interventional oncology market will observe a promising growth outlook. Fewer postoperative complications, a shorter hospital stay, less pain, smaller and more cosmetic incisions, a lower risk of infection, less post-operative care, and a speedier recovery time are the main benefits of minimally invasive procedures. Demand for various interventional oncology products and treatments is increasing due to the rising cancer incidence in these nations.

Modern technology is used to identify and treat diseases like cancer in minimally invasive procedures. These techniques are utilised as an efficient way to remove cancerous lymph nodes and tumours without leaving scars. The collection of tissues for biopsies, and precise staging tests are made possible by minimally invasive surgical methods. In turn, this aids surgeons in developing a clear and appropriate cancer treatment strategy. Significant cost savings are also achieved with minimally invasive procedures. The major competitors in the interventional oncology market are concentrating more and more on introducing cutting-edge products. The focus of innovation in interventional oncology market is the development of affordable, advanced technology and user-friendly interventional oncology systems. Such actions concentrate on enhancing the capability of interventional oncology systems and broadening their application domains, which raises end customers' demand for these systems.

Higher Prevalence of Liver Cancer Substantially Contributes to Interventional Oncology Market

Interventional oncology market is dominated by liver cancer. Since surgically removing the tumour may not leave the surrounding tissue healthy enough for the liver to function correctly, interventional oncology is essential in treating liver cancer. Therefore, interventional oncology treatments can effectively treat primary liver tumours, and those brought back by metastatic cancers. Because of this, interventional oncology is used in more than half of all therapies for both primary and metastatic liver cancer. The significant share of this segment in interventional oncology market may be attributable to several factors, including the rising incidence of liver cancer worldwide and the expansion of research and development efforts to create sophisticated interventional oncology-based liver cancer therapies.

Liver cancer accounts for most of cancer cases worldwide, or 2.09 million instances, according to the WHO. The cancer incidence rate is anticipated to rise as the world's population continues to grow. This aspect is expected to fuel the expansion of interventional oncology market during the scheduled time frame. Initiatives in the form of grants and funding for creating cutting-edge therapies utilising interventional oncology also contribute toward market growth. According to GLOBOCAN 2018, the Asian region saw 609,596 new cases of liver cancer in 2018; by 2025, this number is expected to rise by 142,982. Governments in various developing nations make significant investments in expanding and upgrading their separate healthcare infrastructures due to the rising disease burden. This will continue to influence the performance of interventional oncology market.

Greater Emphasis on Improving Healthcare Industry Uplifts Interventional Oncology Market in Asia Pacific

The Asia Pacific is the largest user of interventional oncology and is expected to grow fastest throughout the forecast period. The commercialisation of cutting-edge interventional procedures and products, along with the supportive regulations for the development of these products, rising healthcare expenditure, and expansion of the research bases in nations like Japan, China, and India are fuelling the growth of the interventional oncology market in this region during the forecast period. Due to the high incidence of cancers in the densely populated nations of China, and India, fast-evolving healthcare systems, numerous government attempts to improve healthcare industry, and rising per capita healthcare spending during the projection period. China saw a rise in healthcare spending in 2016 as fiscal healthcare spending jumped by 10% yearly. The National Health and Family Planning Commission (NHFPC) estimates China's 2016 health budget was US$0.18 Tn. The Ayushman Bharat scheme, launched by the Indian government, will distribute US$7,030 (INR 5 lakh) per family yearly to over 500 million people.

Furthermore, increased investments by top international interventional oncology device firms in the region are anticipated to aid in driving interventional oncology market ahead in Asia Pacific throughout the forecast period. In recent years, hospitals, and healthcare equipment manufacturers have expanded significantly in Asian nations like China, India, Japan, and Singapore. Additionally, Asian consumers are becoming much more aware of the need to improve cancer care, which has grown significantly. In the APAC region, the burden of numerous chronic malignant disorders among the senior population is rising. As a result, interventional oncology has become more widely used. It continues to grow in this region, which may present market prospects for the global interventional oncology industry throughout the projection period. Additionally, IO has improved with the incorporation of cutting-edge technology. Robotics, and AI can speed up operations and increase the accuracy of needle placement. New advancements in this imaging technique for IO may result from the development of therapeutic ultrasound, new 3D imaging techniques, and contrast chemicals. Ultrasonic agents can guide biopsies in regions of aggressive tumours. High intensity targeted ultrasonic ablation is another emerging discipline.

Global Interventional Oncology Market: Competitive Landscape

A few of the players in the interventional oncology market include Instylla (US),  Merit Medical (US),  Medtronic (Ireland), Boston Scientific (US), Terumo (Japan), Trisalus Lifesciences (US),  BD (US), AngioDynamics (US), J&J (US), Trod Medical (US),  Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves (US), Profound Medical Corp (Canada), Sanarus (US), ABK Biomedical (Canada), Interface Biomaterials BV (Netherlands), IMBiotechnologies (Canada), Mermaid Medicals (Denmark),  IceCure Medical (Israel), Guerbet (France), Shape Memory Medical (US), Sirtex (US), Baylis Medical (Canada), Endo Shape (US), Monteris Medical (US), Accuray (US), and ALPINION MEDICAL SYSTEMS (South Korea).

Recent Notable Developments

• In 2022, the purchase of Baylis Medical Company Inc. by Boston Scientific Corporation (NYSE: BSX) was finalised in February 2022. Baylis Medical Company Inc. offers cutting-edge transseptal access devices and guidewires, sheaths, and dilators for catheter-based left heart surgeries
  
  
• In 2021, Preventice Solutions, Inc., a privately held provider of a full range of mobile cardiac health solutions and services, including ambulatory cardiac monitors, short- and long-term Holter monitors, as well as cardiac event monitors, and mobile cardiac telemetry, has reached an agreement to be acquired by Boston Scientific (NYSE: BSX)

Global Interventional Oncology Market is Segmented as Below:

By Product

• Embolization Devices
• Ablation Devices
• Support Devices

By Procedure

• Thermal Tumor Ablation
• Non-Thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
• Transcatheter Arterial Embolization/Bland Embolization

By Cancer Type

• Liver Cancer
• Liver Cancer
• Bone Metastasis
• Kidney Cancer
• Breast Cancer
• Prostate Cancer
• Other Cancers

By End Users

• Hospitals
• Ambulatory Surgery Centers
• Research & Academic Institutes

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Russia
  • Rest of Europe
• Asia Pacific
  • Japan
  • South Korea
  • India
  • China
  • Rest of Asia Pacific
• LAMEA
  • Latin America
  • Middle East
  • Africa

Key Elements Included In The Study: Global Interventional Oncology Market

• Interventional Oncology Market by Product/Technology/Grade, Application/End-user, and Region
• Executive Summary (Opportunity Analysis and Key Trends)
• Historical Market Size and Estimates, Value, 2018 - 2021
• Market Value at Regional and Country Level, 2022 - 2029
• Market Dynamics and Economic Overview
• Market Size in Value, Growth Rates, and Forecast Figures, 2022 - 2029
• Competitive Intelligence with Financials, Key Developments, and Portfolio of Leading Companies 
• Regional and Product/Grade/Application/End-user Price Trends Analysis
• Value Chain and Five Force’s Analysis
• Regional/Sub-region/Country Market Size and Trend Analysis
• Company Market Share Analysis and Key Player Profiles

Post Sale Support, Research Updates & Offerings

We value the trust shown by our customers in Fairfield Market Research. We support our clients through our post sale support, research updates and offerings.

• The report will be prepared in a PPT format and will be delivered in a PDF format.

• Additionally, Market Estimation and Forecast numbers will be shared in Excel Workbook.

• If a report being sold was published over a year ago, we will offer a complimentary copy of the updated research report along with Market Estimation and Forecast numbers within 2-3 weeks’ time of the sale.

• If we update this research study within the next 2 quarters, post purchase of the report, we will offer a Complimentary copy of the updated Market Estimation and Forecast numbers in Excel Workbook.

• If there is a geopolitical conflict, pandemic, recession, and the like which can impact global economic scenario and business activity, which might entirely alter the market dynamics or future projections in the industry, we will create a Research Update upon your request at a nominal charge.

Disclaimer:

• The segmentation/company profiles/countries depicted above may vary in the actual report.